Literature DB >> 11897289

Provision of information about drug side-effects to patients.

D C Berry, P Knapp, D K Raynor.   

Abstract

To make informed decisions about taking medicinal drugs, people need accurate information about side-effects. A European Union guideline now recommends use of qualitative descriptions for five bands of risk, ranging from very rare (affecting <0.01% of the population), to very common (>10%). We did four studies of more than 750 people, whom we asked to estimate the probability of having a side-effect on the basis of qualitative and quantitative descriptions. Our results showed that qualitative descriptions led to gross overestimation of risk. Until further work is done on how patients taking the drugs interpret these terms, the terms should not be used in drug information leaflets.

Entities:  

Mesh:

Year:  2002        PMID: 11897289     DOI: 10.1016/s0140-6736(02)07923-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  25 in total

1.  What information do patients need about medicines? Ask the patients--they may want to know more than you think.

Authors:  David Dickinson; D K Theo Raynor
Journal:  BMJ       Date:  2003-10-11

2.  Assessing the benefit-harm balance at the bedside.

Authors:  Yoon Kong Loke
Journal:  BMJ       Date:  2004-07-03

3.  Combined verbal and numerical expressions increase perceived risk of medicine side-effects: a randomized controlled trial of EMA recommendations.

Authors:  Peter Knapp; Peter H Gardner; Elizabeth Woolf
Journal:  Health Expect       Date:  2015-01-26       Impact factor: 3.377

4.  Patients' expectations of screening and preventive treatments.

Authors:  Ben Hudson; Abby Zarifeh; Lorraine Young; J Elisabeth Wells
Journal:  Ann Fam Med       Date:  2012 Nov-Dec       Impact factor: 5.166

5.  Risk communication methods in hip fracture prevention: a randomised trial in primary care.

Authors:  Ben Hudson; Les Toop; Dee Mangin; John Pearson
Journal:  Br J Gen Pract       Date:  2011-08       Impact factor: 5.386

6.  Risk communication in clinical trials: a cognitive experiment and a survey.

Authors:  Yin Bun Cheung; Hwee Lin Wee; Julian Thumboo; Cynthia Goh; Ricardo Pietrobon; Han Chong Toh; Yu Fen Yong; Say Beng Tan
Journal:  BMC Med Inform Decis Mak       Date:  2010-09-27       Impact factor: 2.796

7.  Comparison of two methods of presenting risk information to patients about the side effects of medicines.

Authors:  P Knapp; D K Raynor; D C Berry
Journal:  Qual Saf Health Care       Date:  2004-06

Review 8.  Patients' understanding of risk associated with medication use: impact of European Commission guidelines and other risk scales.

Authors:  Dianne C Berry; D K Raynor; Peter Knapp; Elisabetta Bersellini
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

9.  Adequacy of patient information on adverse effects: an assessment of patient information leaflets in the UK.

Authors:  Neil Carrigan; D K Raynor; Peter Knapp
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 10.  Written information about individual medicines for consumers.

Authors:  Donald Nicolson; Peter Knapp; D K Theo Raynor; Pat Spoor
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.